Soumit Roy
Stock Analyst at Jones Trading
(0.25)
# 3,440
Out of 4,555 analysts
22
Total ratings
13.33%
Success rate
-27.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INAB IN8bio | Downgrades: Hold | n/a | $0.31 | - | 3 | Aug 12, 2024 | |
| SAVA Cassava Sciences | Downgrades: Hold | n/a | $26.93 | - | 2 | Jul 1, 2024 | |
| CRVO CervoMed | Initiates: Buy | $70 | $15.98 | +338.05% | 1 | May 29, 2024 | |
| BOLT Bolt Biotherapeutics | Downgrades: Hold | n/a | $0.63 | - | 1 | May 15, 2024 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $22 → $26 | $18.25 | +42.47% | 2 | Apr 17, 2024 | |
| JANX Janux Therapeutics | Initiates: Buy | $70 | $41.85 | +67.26% | 1 | Apr 16, 2024 | |
| MNPR Monopar Therapeutics | Upgrades: Buy | $10 | $2.40 | +316.67% | 2 | Apr 11, 2024 | |
| TCON TRACON Pharmaceuticals | Downgrades: Hold | n/a | $0.06 | - | 2 | Aug 21, 2023 | |
| ACRV Acrivon Therapeutics | Initiates: Buy | $26 | $7.90 | +229.11% | 1 | Aug 18, 2023 | |
| ONCY Oncolytics Biotech | Initiates: Buy | $9 | $0.93 | +867.74% | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $0.19 | +2,031.06% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.39 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $0.55 | +1,344.04% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $1.48 | - | 1 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $10.27 | +7,787.05% | 1 | Feb 24, 2021 |
IN8bio
Aug 12, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.31
Upside: -
Cassava Sciences
Jul 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $26.93
Upside: -
CervoMed
May 29, 2024
Initiates: Buy
Price Target: $70
Current: $15.98
Upside: +338.05%
Bolt Biotherapeutics
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.63
Upside: -
Cullinan Therapeutics
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $18.25
Upside: +42.47%
Janux Therapeutics
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $41.85
Upside: +67.26%
Monopar Therapeutics
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $2.40
Upside: +316.67%
TRACON Pharmaceuticals
Aug 21, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.06
Upside: -
Acrivon Therapeutics
Aug 18, 2023
Initiates: Buy
Price Target: $26
Current: $7.90
Upside: +229.11%
Oncolytics Biotech
May 24, 2023
Initiates: Buy
Price Target: $9
Current: $0.93
Upside: +867.74%
Apr 19, 2023
Initiates: Buy
Price Target: $4
Current: $0.19
Upside: +2,031.06%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.39
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $8
Current: $0.55
Upside: +1,344.04%
Apr 29, 2021
Initiates: Buy
Price Target: n/a
Current: $1.48
Upside: -
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $10.27
Upside: +7,787.05%